An agreement amounting more than 500 million U.S. dollars between Greek- Swiss pharmaceutical and clinical research group Sellas Clinicals Holding and Chinese pharmaceutical conglomerate Fosun Pharma for the development and marketing of two ...
Shanghai Fosun Pharma, a China-based company, has announced that it will jointly invest $240m with Pramerica-Fosun China Opportunity Fund to purchase around 95.6% share of Israel-based Alma Lasers. Alma Lasers is a global medical and ...
Tags: Fosun Pharma, Alma Lasers